Guobang Pharma Ltd. (605507.SH) has accumulated repurchased 1.04% of its shares, spending 112 million yuan.
Guobang Pharmaceutical (605507.SH) announced that as of November 18, 2025, the company has completed trading through centralized auction.
Announcement from Guobang Pharma Ltd. (605507.SH): As of November 18, 2025, the company has repurchased a total of 5.7866 million shares through centralized auction trading, representing 1.04% of the total share capital. The total amount paid for the repurchase is 112 million yuan (excluding transaction fees).
Related Articles
Techtronic Industries (00669) spent HKD 42.1095 million on November 19th to repurchase 500,000 shares.
BJ ENT WATER (00371) completion of issuing 2 billion yuan of medium-term notes.
On November 19, WEIGAO GROUP (01066) spent HK$1.8484 million to repurchase 350,800 shares.
Techtronic Industries (00669) spent HKD 42.1095 million on November 19th to repurchase 500,000 shares.
BJ ENT WATER (00371) completion of issuing 2 billion yuan of medium-term notes.
On November 19, WEIGAO GROUP (01066) spent HK$1.8484 million to repurchase 350,800 shares.
RECOMMEND
Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
18/11/2025
Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
18/11/2025
Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
18/11/2025
